Letermovir Related Compounds & Impurities

Letermovir is a viral terminase complex inhibitor with a novel mechanism distinct from nucleoside analogues, used for CMV prophylaxis in stem cell transplant recipients.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Letermovir reference standards, pharmacopeial and non-pharmacopeial Letermovir impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Letermovir-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Letermovir
Letermovir N-Oxide
Letermovir Impurity 11
Letermovir Impurity 14
Letermovir Impurity 9
Letermovir Impurity 7
Letermovir Impurity 15
Letermovir Impurity 16
Letermovir Ethyl Ester
Letermovir Impurity 17
Letermovir Impurity 1
3-Fluoro Letermovir
4-Fluoro Letermovir
5-Fluoro Letermovir
Letermovir Impurity 2
Letermovir Impurity 3
Letermovir Impurity 18
Letermovir Nitroso Impurity 2
Letermovir Impurity 21
Letermovir Impurity 22
Letermovir Impurity 19
Letermovir Impurity 20
Letermovir Impurity 23
Letermovir Impurity 24
Letermovir Impurity 12
Letermovir Impurity 25
Letermovir Impurity 26
Letermovir Impurity 27
Letermovir Impurity 5
Letermovir Impurity 4
Letermovir Impurity 25
Letermovir Impurity 6
Letermovir Impurity 8
Letermovir Impurity 8
Letermovir Impurity 10
Letermovir Impurity 13
Letermovir Impurity 28
Letermovir Impurity 29
Letermovir Impurity 30
Letermovir Impurity 31
Letermovir Impurity 32
Letermovir Impurity 33
Letermovir Impurity 34
Letermovir Impurity 35

Isotope Labelled Compounds

Letermovir-d3
Letermovir-d6
Letermovir 13CD3
Letermovir-D6 (Racemic)
rac Letermovir D8